ACAD Average Annual Return 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into ACAD


Also see:
ACAD stock yearly return 2011
ACAD stock yearly return 2012
ACAD stock yearly return 2013
ACAD stock yearly return 2014
ACAD stock yearly return 2015
ACAD stock yearly return 2016
ACAD stock yearly return 2017
ACAD stock yearly return 2018
ACAD stock yearly return 2019
ACAD stock yearly return 2020
ACAD YTD return
Compare ACAD average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 12/06/2011
End date: 12/03/2021
Start price/share: $1.04
End price/share: $18.79
Dividends collected/share: $0.00
Total return: 1,706.73%
ACAD Average Annual Return: 33.56%
Starting investment: $10,000.00
Ending investment: $180,619.28
Years: 10.00


ACAD average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines focusing on central nervous system disorders. Co. has a portfolio of product including its drug, NUPLAZID (pimavanserin), which has been approved by the U.S. Food and Drug Administration for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PD Psychosis). NUPLAZID is a selective serotonin inverse agonist preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. The ACAD average annual return 10 years is shown above.

The Average Annual Return on the ACAD average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether ACAD average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ACAD average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree ACAD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Acadia Pharmaceuticals (ACAD) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ACCD Average Annual Return
ACER Average Annual Return
ACET Average Annual Return
ACHC Average Annual Return
ACHV Average Annual Return
ACOR Average Annual Return
ACRS Average Annual Return
ACRX Average Annual Return
ACST Average Annual Return
ACXP Average Annual Return
More Healthcare companies »

★★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, Acadia Pharmaceuticals (ACAD) ranks in the top 25% of all stocks whose returns we have reviewed.
What has the average annual return been for ACAD over the past ten years?
✔️Accepted answer: The ten year ACAD average annual return has been 33.56%.

What start date was used in your ACAD average annual return calculation?
✔️Accepted answer: The start date was 12/06/2011.

What end date was used in your ACAD average annual return calculation?
✔️Accepted answer: The end date was 12/03/2021.

If I had invested $10,000 into ACAD ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 12/03/2021, you would have $180,619.28.

What does that work out to on a total return basis?
✔️Accepted answer: The ACAD ten year total return ending 12/03/2021 works out to 1,706.73%.


Also see:
ACAD stock yearly return 2011
ACAD stock yearly return 2012
ACAD stock yearly return 2013
ACAD stock yearly return 2014
ACAD stock yearly return 2015
ACAD stock yearly return 2016
ACAD stock yearly return 2017
ACAD stock yearly return 2018
ACAD stock yearly return 2019
ACAD stock yearly return 2020
ACAD YTD return
 

ACAD Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.